Concepedia

Publication | Closed Access

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

DOI

230

Citations

6

References

2013

Year

Krzysztof Selmaj, David K.B. Li, Hans-Peter Hartung, Bernhard Hemmer, Ludwig Kappos, Mark S. Freedman, Olaf Stüve, Peter Rieckmann, Xavier Montalbán, Tjalf Ziemssen,
The Lancet Neurology

References

YearCitations

Page 1